ImmuONE, a Stevenage, UK-based biotech startup developing a 3D laboratory model that provides an alternative to animal testing, raised £600K in funding.
Backers included the Midlands Engine Investment Fund, Mercia Ventures and Pioneer Group.
The company intends to use the funds to develop its capabilities, target new sectors such as agrichemicals and automotive, and expand its team with the appointment of two new scientists.
Founded in 2019 by Dr Abigail Martin and Professor Victoria Hutter from the University of Hertfordshire, ImmuONE is a biotech startup with a 3D human lung model that enables companies to replace or reduce the need for animal testing. In addition to respiratory safety tests, it now offers more complex immunology tests which show the long-term effects of substances on the lung including the potential to cause inflammation. It has also taken on board new clients in the chemicals sector, building on its existing customer base of consumer products and pharmaceutical companies.
FinSMEs
13/03/2025